Pattern: Biotech CEO explains how he'll use fresh $9M
The company's "faster bacterial tests can reduce the risk of antibiotic misuse" with Covid-19 patients - and those suffering from other viral respiratory infections. It is now hiring and preparing for clinical trials, with an additional $9 million in the bank.
Read full article »
Pattern is a Texas-based biotechnology company that provides services such as rapid diagnosis and antibiotic susceptibility testing for bacterial infections.
Read more